Summary:
- Researchers have developed an experimental drug, ACVR2B, that promotes fat loss in obese mice by specifically targeting adipose tissue while preserving lean muscle mass.
- Unlike traditional weight-loss interventions that often result in muscle wasting or require caloric restriction, this treatment appears to selectively increase metabolic activity and fat oxidation without altering the subjects' food intake.